Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 May 2025

View source ↗

Summary

PRAC concluded its safety review of medicines containing finasteride and dutasteride; the meeting highlights outline the committee's conclusions and any propose…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia
• Benign Prostatic Hyperplasia

Drugs mentioned

• DUTASTERIDE (Dutasteride)
• FINASTERIDE (FINASTERIDE)

Snippet

Review of medicines containing finasteride and dutasteride concluded